SPRY
ARS Pharmaceuticals is focused on enhancing safety for individuals at risk of severe allergic reactions through innovative solutions. They are developing ARS-1, an intranasal epinephrine spray designed for comfort and reliability, aimed at providing an easier and more effective way for patients and caregivers to manage anaphylaxis due to food, medications, and insect stings.
No recent news for this company.
No recent deals for this company.